Risk factor
Good trading liquidity
Profitability factor
Favourable analyst view
About
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products....
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of DIM.PA is 250 and suggests 43% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell